Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre
Crossref DOI link: https://doi.org/10.1007/s11845-017-1582-3
Published Online: 2017-02-24
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sharif, Z.
Srinivas, B.
Tiedt, I.
Ryan, N.
Awadalla, M.
Sullivan, V.
Foley, D. P.
Gumbrielle, T.
McAdam, B.
Sheahan, R. G.
License valid from 2017-02-24